Sign Up to like & get
recommendations!
1
Published in 2018 at "Bioanalysis"
DOI: 10.4155/bio-2017-0208
Abstract: AIM Recombinant FGF21 analogs are under wide ranging investigations as a potential therapeutic agent for Type 2 diabetes, as well as other metabolic disorders. The endogenous FGF21 is often used as a surrogate pharmacodynamic(PD) biomarker…
read more here.
Keywords:
immunocapture;
highly selective;
active forms;
selective sensitive ... See more keywords